Back
Swedbank AB Vs. Rhythm Pharmaceuticals Industry Stock Comparison
Buy
67
SWDBY
Swedbank AB
Last Price:
$25.15
Seasonality Move:
5.29%
Buy
57
RYTM
Rhythm Pharmaceuticals
Last Price:
$64.05
Seasonality Move:
14.49%
Buy
67
Swedbank AB (SWDBY)
is a Buy
Is Swedbank AB a Buy, Sell or Hold?
-
The current Swedbank AB [SWDBY] share price is $25.15. The Score for SWDBY is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
-
SWDBY is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
57
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals [RYTM] share price is $64.01. The Score for RYTM is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
RYTM is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SWDBY Stock Price Chart
What is Swedbank AB's stock price today?
-
The Swedbank AB share price today is $25.15Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SWDBY is experiencing slight buying pressure.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $64.01Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing selling pressure, which indicates risk of future bearish movement.
SWDBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.36 | Buy |
| Relative Strength Index (14 RSI): | 64.43 | Buy |
| Chaikin Money Flow: | 1345 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.23 - 24.11) | Buy |
| Bollinger Bands (100): | (20.39 - 24.65) | Buy |
RYTM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.59 | Buy |
| Relative Strength Index (14 RSI): | 61.82 | Buy |
| Chaikin Money Flow: | -423346 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (53.72 - 63.96) | Buy |
| Bollinger Bands (100): | (52.92 - 60.34) | Buy |
SWDBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 24.1 | Buy |
| 20-day SMA: | 22.62 | Buy |
| 50-day SMA: | 23.97 | Buy |
| 200-day SMA: | 21.5 | Buy |
| 8-day EMA: | 24.22 | Buy |
| 20-day EMA: | 23.57 | Buy |
| 50-day EMA: | 23.34 | Buy |
| 200-day EMA: | 21.87 | Buy |
RYTM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 63.65 | Buy |
| 20-day SMA: | 60.57 | Buy |
| 50-day SMA: | 55.98 | Buy |
| 200-day SMA: | 53.96 | Buy |
| 8-day EMA: | 63.48 | Buy |
| 20-day EMA: | 60.94 | Buy |
| 50-day EMA: | 58.06 | Buy |
| 200-day EMA: | 53.2 | Buy |
Swedbank AB Earnings Growth & SWDBY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.32 per share, and an increase next year of $0.08 per share.
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.26 per share, an increase next quarter of $0.07 per share, an increase this year of $1.54 per share, and an increase next year of $1.14 per share.
Swedbank AB Technical Analysis
| Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 28 | Apr 29 | Apr 30 | May 1 | May 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Rhythm Pharmaceuticals Technical Analysis
| Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 28 | Apr 29 | Apr 30 | May 1 | May 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 21 | 22 | 23 | 24 | 25 | 28 | 29 | 30 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||